Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 3Warts 1Vaginal Diseases 1Uterine Cervical Neoplasms 1Recurrence 1Pneumonia, Pneumococcal 1Pneumococcal Infections 1Papillomavirus Infections 1Neoplasms 1Multiple Myeloma 1Immunologic Deficiency Syndromes 1Hematologic Neoplasms 1Glioma 1Febrile Neutropenia 1Esophageal Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Condylomata Acuminata 1Cervical Cancer Screening 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Oxaliplatin 46Gemcitabine 45Fluorouracil 40Capecitabine 31pembrolizumab 30Leucovorin 29Docetaxel 27Cisplatin 25Paclitaxel 23Irinotecan 18Carboplatin 18Bevacizumab 18130-nm albumin-bound paclitaxel 17Radiotherapy 16Pemetrexed 15Albumin-Bound Paclitaxel 15Nivolumab 13Ramucirumab 11Cyclophosphamide 11Drug Therapy 9Trastuzumab 8Erlotinib Hydrochloride 8zolbetuximab 7Taxes 7Radiosurgery 7trastuzumab deruxtecan 6cemiplimab 6Blood Specimen Collection 6regorafenib 5durvalumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma × Vaccination × Clear all
NCT01342224 2018-04-12

Immunochemoradiotherapy in Patients With Pancreatic Cancer

Providence Health & Services

Phase 1 Completed
11 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡